UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation

Annals of the New York Academy of Sciences, 2018-04, Vol.1417 (1), p.5-22

2018

Volltextzugriff (PDF)

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

Nature Reviews: Immunology, 2007-08, Vol.7 (8), p.585-598

2007

Volltextzugriff (PDF)

Gene correction for SCID-X1 in long-term hematopoietic stem cells

Nature communications, 2019-04, Vol.10 (1), p.1634-1634, Article 1634

2019

Volltextzugriff (PDF)

In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases

Cell stem cell, 2016-07, Vol.19 (1), p.107-119

2016

Volltextzugriff (PDF)

Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome

Blood, 2009-06, Vol.113 (25), p.6288-6295

2009

Volltextzugriff (PDF)

Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry

The Journal of immunology (1950), 2018-01, Vol.200 (1), p.336-346

2018

Volltextzugriff (PDF)

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

The New England journal of medicine, 2009-07, Vol.361 (5), p.478-488

2009

Volltextzugriff (PDF)

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

Immunological reviews, 2011-05, Vol.241 (1), p.145-163

2011

Volltextzugriff (PDF)

Role of regulatory T cells and FOXP3 in human diseases

Journal of allergy and clinical immunology, 2007-08, Vol.120 (2), p.227-235

2007

Volltextzugriff (PDF)

HLA-G expression levels influence the tolerogenic activity of human DC-10

Haematologica (Roma), 2015-04, Vol.100 (4), p.548-557

2015

Volltextzugriff (PDF)

Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo

Clinical & translational immunology, 2020, Vol.9 (11), p.e1214-n/a

2020

Volltextzugriff (PDF)

Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes

Stem cells (Dayton, Ohio), 2016-04, Vol.34 (4), p.809-819

2016

Volltextzugriff (PDF)

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

EMBO molecular medicine, 2017-06, Vol.9 (6), p.737-740

2017

Volltextzugriff (PDF)

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products

Molecular therapy. Methods & clinical development, 2023-12, Vol.31, p.101150-101150, Article 101150

2023

Volltextzugriff (PDF)

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome

Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.692-702.e2

2015

Volltextzugriff (PDF)

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

Haematologica (Roma), 2011-09, Vol.96 (9), p.1357-1365

2011

Volltextzugriff (PDF)

Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance

Diabetes (New York, N.Y.), 2006-01, Vol.55 (1), p.40-49

2006

Volltextzugriff (PDF)

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

Diabetes (New York, N.Y.), 2010-02, Vol.59 (2), p.433-439

2010

Volltextzugriff (PDF)

Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity

Journal of allergy and clinical immunology, 2008-12, Vol.122 (6), p.1105-1112.e1

2008

Volltextzugriff (PDF)

Engineered T Regulatory Type 1 Cells for Clinical Application

Frontiers in immunology, 2018-02, Vol.9, p.233-233

2018

Volltextzugriff (PDF)

Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation

Frontiers in immunology, 2019-07, Vol.10, p.1342

2019

Volltextzugriff (PDF)

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway

Blood, 2010-08, Vol.116 (6), p.935-944

2010

Volltextzugriff (PDF)

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans

Immunological reviews, 2006-08, Vol.212 (1), p.28-50

2006

Volltextzugriff (PDF)

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells

Nature communications, 2019-04, Vol.10 (1), p.2021-2021, Article 2021

2019

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(377)
Mit Volltextzugriff
(357)

Publikationsform

Sprache

Englisch
(405)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Life Sciences & Biomedicine
(236)
Humans
(227)
Immunology
(120)
Animals
(111)
Biological And Medical Sciences
(94)
Mice
(83)
Female
(66)
Medical Sciences
(65)
Male
(62)
Medicine, Research & Experimental
(59)
Research & Experimental Medicine
(59)
Hematology
(57)
T-Lymphocytes, Regulatory - Immunology
(56)
Fundamental And Applied Biological Sciences. Psychology
(49)
Gene Therapy
(46)
T-Lymphocytes - Immunology
(44)
Hematopoietic Stem Cell Transplantation
(42)
Child
(38)
Lymphocytes
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

Gene correction for SCID-X1 in long-term hematopoietic stem cells

In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases

Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome

Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

Role of regulatory T cells and FOXP3 in human diseases

HLA-G expression levels influence the tolerogenic activity of human DC-10

Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo

Concise Review: Cell‐Based Therapies and Other Non‐Traditional Approaches for Type 1 Diabetes

Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance

Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant

Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: Inconsistent correlation between forkhead box protein 3 expression and disease severity

Engineered T Regulatory Type 1 Cells for Clinical Application

Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation

Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10–dependent ILT4/HLA-G pathway

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells

Suchergebnisse filtern